Researchmoz added Most up-to-date research on "Global Radiopharmaceuticals Market 2017-2021" to its huge collection of research reports.
Radiopharmaceuticals are pharmaceutical drugs having radioactive properties. The drugs can be used for therapeutic and diagnostic purposes. It is made up of radioisotope that bonds to an organic molecule. The radiopharmaceuticals find large application in the medical field due to their intrinsic properties. The radiopharmaceutical market is expected to benefit from the growing demand from the cancer market. Cancer is one of the major segments having a huge demand for radiopharmaceuticals for both therapeutic and diagnostic segments. Some of the other major segments finding the huge application of radiopharmaceuticals are neurology, cardiology, and thyroid disorder treatment.
Technavios analysts forecast the global radiopharmaceuticals market to grow at a CAGR of 9.02% during the period 2017-2021.
To Get Sample Copy of Report visit @ http://www.researchmoz.us/enquiry.php?type=S&repid=1293340
Covered in this report
The report covers the present scenario and the growth prospects of the global radiopharmaceuticals market for 2017-2021. To calculate the market size, the report considers the sales of radiopharmaceuticals.
The market is divided into the following segments based on geography:
Americas
APAC
EMEA
Global Radiopharmaceuticals Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
Key vendors
Bayer,
Cardinal Health,
GE Healthcare,
Lantheus Medical Imaging
Browse Detail Report With Full TOC @ http://www.researchmoz.us/global-radiopharmaceuticals-market-2017-2021-report.html
Other prominent vendors
ABT Molecular Imaging
Advanced Accelerator Applications
Algeta
Eczacibasi-Monrol Nuclear Products
FUJIFILM Holdings
Isologic Innovative Radiopharmaceuticals
Nordion
Piramal Imaging
RadioMedix
Triad Isotopes
Market driver
Rising burden of the neurological disorders
For a full, detailed list, view our report
Market challenge
Shortage of radioisotopes
For a full, detailed list, view our report
Market trend
Partnerships for development of radiopharmaceuticals
For a full, detailed list, view our report
Key questions answered in this report
What will the market size be in 2021 and what will the growth rate be?
What are the key market trends?
What is driving this market?
What are the challenges to market growth?
Who are the key vendors in this market space?
What are the market opportunities and threats faced by the key vendors?
What are the strengths and weaknesses of the key vendors?
Make an Enquiry of this report @ http://www.researchmoz.us/enquiry.php?type=E&repid=1293340
Radiopharmaceuticals are pharmaceutical drugs having radioactive properties. The drugs can be used for therapeutic and diagnostic purposes. It is made up of radioisotope that bonds to an organic molecule. The radiopharmaceuticals find large application in the medical field due to their intrinsic properties. The radiopharmaceutical market is expected to benefit from the growing demand from the cancer market. Cancer is one of the major segments having a huge demand for radiopharmaceuticals for both therapeutic and diagnostic segments. Some of the other major segments finding the huge application of radiopharmaceuticals are neurology, cardiology, and thyroid disorder treatment.
Technavios analysts forecast the global radiopharmaceuticals market to grow at a CAGR of 9.02% during the period 2017-2021.
To Get Sample Copy of Report visit @ http://www.researchmoz.us/enquiry.php?type=S&repid=1293340
Covered in this report
The report covers the present scenario and the growth prospects of the global radiopharmaceuticals market for 2017-2021. To calculate the market size, the report considers the sales of radiopharmaceuticals.
The market is divided into the following segments based on geography:
Americas
APAC
EMEA
Global Radiopharmaceuticals Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
Key vendors
Bayer,
Cardinal Health,
GE Healthcare,
Lantheus Medical Imaging
Browse Detail Report With Full TOC @ http://www.researchmoz.us/global-radiopharmaceuticals-market-2017-2021-report.html
Other prominent vendors
ABT Molecular Imaging
Advanced Accelerator Applications
Algeta
Eczacibasi-Monrol Nuclear Products
FUJIFILM Holdings
Isologic Innovative Radiopharmaceuticals
Nordion
Piramal Imaging
RadioMedix
Triad Isotopes
Market driver
Rising burden of the neurological disorders
For a full, detailed list, view our report
Market challenge
Shortage of radioisotopes
For a full, detailed list, view our report
Market trend
Partnerships for development of radiopharmaceuticals
For a full, detailed list, view our report
Key questions answered in this report
What will the market size be in 2021 and what will the growth rate be?
What are the key market trends?
What is driving this market?
What are the challenges to market growth?
Who are the key vendors in this market space?
What are the market opportunities and threats faced by the key vendors?
What are the strengths and weaknesses of the key vendors?
Make an Enquiry of this report @ http://www.researchmoz.us/enquiry.php?type=E&repid=1293340
No comments:
Post a Comment